Skip to main content
. Author manuscript; available in PMC: 2017 Sep 5.
Published in final edited form as: Int J Oncol. 2010 Mar;36(3):601–606. doi: 10.3892/ijo_00000535

Figure 2.

Figure 2

(A) Overall survival was not statistically different between patients who were ≥65 years of age vs. younger: median survival of 6.0 months vs. 6.7 months (p=0.45). (B) Cancer progression-free survival was not statistically different between patients who were ≥65 years of age vs. younger: median survival of 3.3 months in both groups (p=0.46).